PCOS showdown: which drug tames hormones better?
NCT ID NCT07459595
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two drugs—metformin and myo-inositol—for managing polycystic ovary syndrome (PCOS) in 60 women. Over 3 months, researchers will check if either drug helps restore regular menstrual cycles and improve hormone balance. The goal is to see which option works better for common PCOS symptoms like irregular periods and excess hair growth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Metformin and myo-inositol
- What this could lead to
- If one works better, it could offer a simpler, more effective option for managing PCOS symptoms like irregular periods and hormone levels.
- What could go wrong
- This is a very early, small phase 1 trial with only 60 participants, so results may not apply broadly. Both drugs have known side effects like stomach upset.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARIAN SYNDROME (PCOS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CMH Gujranwala
Guiranwala, Punjab Province, 52230, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a daily powder ease PCOS symptoms? a trial puts it to the test.
- Ancient herb meets modern science: could ashwagandha ease PCOS symptoms?
- Probiotic drink may ease PCOS-Related fertility issues
- Could deep breathing exercises help women with PCOS sleep better?
- Mind over PCOS: theta healing trial targets fertility fears
- Ancient herb takes on PCOS: new hope for millions?